Concourse Financial Group Securities’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3
Closed -$540 – 2396
2024
Q2
$428 Hold
3
– – ﹤0.01% 2212
2024
Q1
$469 Hold
3
– – ﹤0.01% 2218
2023
Q4
$541 Hold
3
– – ﹤0.01% 2176
2023
Q3
$539 Hold
3
– – ﹤0.01% 2167
2023
Q2
$534 Buy
+3
New +$691 ﹤0.01% 2223
2023
Q1
– Sell
-5
Closed -$1.2K – 2453
2022
Q4
$1.1K Hold
5
– – ﹤0.01% 2154
2022
Q3
$1K Sell
5
-3
-38% -$515 ﹤0.01% 1950
2022
Q2
$1K Sell
8
-1
-11% -$156 ﹤0.01% 2160
2022
Q1
$2K Buy
9
+5
+125% +$1.06K ﹤0.01% 2066
2021
Q4
$1K Buy
4
+2
+100% +$675 ﹤0.01% 2337
2021
Q3
$1K Hold
2
– – ﹤0.01% 2367
2021
Q2
$1K Hold
2
– – ﹤0.01% 2328
2021
Q1
$1K Buy
+2
New +$662 ﹤0.01% 2299
2020
Q4
– Sell
-16
Closed -$4.41K – 2374
2020
Q3
$5K Buy
16
+5
+45% +$1.18K ﹤0.01% 1821
2020
Q2
$2K Hold
11
– – ﹤0.01% 1948
2020
Q1
$1K Hold
11
– – ﹤0.01% 2118
2019
Q4
$2K Buy
+11
New +$1.83K ﹤0.01% 1941
2019
Q3
– Sell
-11
Closed -$1.46K – 2187
2019
Q2
$1K Sell
11
-6
-35% -$762 ﹤0.01% 2157
2019
Q1
$2K Sell
17
-6
-26% -$810 ﹤0.01% 2079
2018
Q4
$3K Hold
23
– – ﹤0.01% 1862
2018
Q3
$4K Buy
+23
New +$3.87K ﹤0.01% 1481

Other funds holding ONC

Concourse Financial Group Securities's ONC Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 3 shares — an estimated $540 sold.

Concourse Financial Group Securities first reported a position in ONC in Q3 2018 and held it in 21 quarters. The position peaked at $5K in Q3 2020. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Concourse Financial Group Securities reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 3 BeOne Medicines Ltd shares in Q3 2024, an estimated $540.
  • Concourse Financial Group Securities first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 21 quarters.
  • Concourse Financial Group Securities's BeOne Medicines Ltd position peaked at $5K in Q3 2020.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.